abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir]
RxNorm concept 285028, branded drug (sbd). Prescribable name: TRIZIVIR 300 MG / 150 MG / 300 MG Oral Tablet.
- RxCUI
- 285028
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/285028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Trizivir (abacavir 300 MG / lamiVUDine 150 MG / zidovudine 300 MG) Oral Tablet; Trizivir (abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG) Oral Tablet; abacavir 300 MG / 3TC 150 MG / AZT 300 MG Oral Tablet [Trizivir]; abacavir 300 MG / lamiVUDine 150 MG / zidovudine 300 MG Oral Tablet [Trizivir]
Related concepts
- lamivudine 150 MG (SCDC, consists of)
- zidovudine 300 MG (SCDC, consists of)
- abacavir 300 MG (SCDC, consists of)
- abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG [Trizivir] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Trizivir (BN, has ingredient)
- abacavir 300 MG / lamivudine 150 MG / zidovudine 300 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 49702021718
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 285028 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/285028 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 285028. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.